金陵药业
(000919)
| 流通市值：41.41亿 | | | 总市值：41.42亿 |
| 流通股本：6.22亿 | | | 总股本：6.22亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,416,941,610.48 | 1,263,403,034.01 | 1,517,007,184.22 | 1,258,449,327.87 |
| 结算备付金 | - | 0 | 0 | 0 |
| 拆出资金 | - | 0 | 0 | 0 |
| 交易性金融资产 | 1,222,562,204.38 | 1,213,197,614.46 | 939,314,534.86 | 1,197,633,148.59 |
| 衍生金融资产 | - | 0 | 0 | 0 |
| 应收票据及应收账款 | 584,575,983.12 | 734,145,795.71 | 689,450,756.53 | 694,769,970.94 |
| 其中：应收票据 | 194,216,853.38 | 223,405,933.87 | 281,333,848.64 | 180,122,707 |
| 应收账款 | 390,359,129.74 | 510,739,861.84 | 408,116,907.89 | 514,647,263.94 |
| 应收款项融资 | 7,669,095.18 | 7,911,956.22 | 1,500,000 | 0 |
| 预付款项 | 9,066,715.92 | 6,639,716.35 | 6,245,643.03 | 4,339,256.26 |
| 应收保费 | - | 0 | 0 | 0 |
| 应收分保账款 | - | 0 | 0 | 0 |
| 应收分保合同准备金 | - | 0 | 0 | 0 |
| 其他应收款合计 | 6,139,380.35 | 5,620,053.7 | 5,424,318.18 | 7,072,936.77 |
| 其中:应收利息 | - | 0 | - | 0 |
| 应收股利 | - | 0 | - | 0 |
| 买入返售金融资产 | - | 0 | - | 0 |
| 存货 | 202,304,388.68 | 219,597,853.59 | 233,142,972.6 | 267,148,507.03 |
| 合同资产 | - | 0 | 0 | 0 |
| 一年内到期的非流动资产 | 268,535,125.58 | 289,897,789.17 | 393,026,213.81 | 103,503,835.6 |
| 其他流动资产 | 12,281,704.51 | 11,372,936.36 | 12,636,357.06 | 11,048,304.93 |
| 流动资产合计 | 3,730,076,208.2 | 3,751,786,749.57 | 3,797,747,980.29 | 3,543,965,287.99 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | 0 | - | 0 |
| 债权投资 | - | 0 | - | 0 |
| 其他债权投资 | - | 0 | - | 0 |
| 长期应收款 | - | 0 | - | 0 |
| 长期股权投资 | 61,131,622.87 | 60,039,583.65 | 62,374,352.09 | 60,632,605.62 |
| 其他权益工具投资 | - | 0 | 0 | 0 |
| 其他非流动金融资产 | - | 0 | 0 | 0 |
| 投资性房地产 | 7,071,386.12 | 7,306,253.26 | 7,542,654.79 | 7,779,117.4 |
| 固定资产 | 1,332,812,534.12 | 1,350,371,312.11 | 1,378,314,202.56 | 1,364,633,683.76 |
| 在建工程 | 72,338,949.28 | 51,617,481.07 | 48,161,902.57 | 88,828,898.04 |
| 生产性生物资产 | 546,310.92 | 580,031.25 | 613,751.58 | 987,076.98 |
| 油气资产 | - | 0 | 0 | 0 |
| 使用权资产 | 28,191,976.28 | 29,082,123.04 | 29,949,477.22 | 29,689,794.88 |
| 无形资产 | 310,630,525.81 | 317,749,496.48 | 322,925,287.16 | 322,865,087.06 |
| 开发支出 | - | 0 | 0 | 0 |
| 商誉 | 44,373,040.7 | 44,373,040.7 | 44,373,040.7 | 62,418,871.63 |
| 长期待摊费用 | 114,318,713.04 | 116,879,598.52 | 120,550,024.56 | 74,929,060.59 |
| 递延所得税资产 | 11,232,055.11 | 13,164,477.39 | 12,609,488.75 | 14,443,702.46 |
| 其他非流动资产 | 279,341,456.43 | 273,318,639.43 | 181,650,798.03 | 452,823,761.1 |
| 非流动资产合计 | 2,261,988,570.68 | 2,264,482,036.9 | 2,209,064,980.01 | 2,480,031,659.52 |
| 资产总计 | 5,992,064,778.88 | 6,016,268,786.47 | 6,006,812,960.3 | 6,023,996,947.51 |
| 流动负债: | | | | |
| 短期借款 | - | 0 | - | 0 |
| 向中央银行借款 | - | 0 | - | 0 |
| 吸收存款及同业存放 | - | 0 | 0 | 0 |
| 拆入资金 | - | 0 | - | 0 |
| 交易性金融负债 | - | 0 | - | 0 |
| 衍生金融负债 | - | 0 | - | 0 |
| 应付票据及应付账款 | 538,960,573.48 | 543,656,660.62 | 554,970,679.38 | 551,091,423.09 |
| 其中：应付票据 | 8,957,464.26 | 34,503,179.71 | 42,593,807.97 | 40,567,960.59 |
| 应付账款 | 530,003,109.22 | 509,153,480.91 | 512,376,871.41 | 510,523,462.5 |
| 预收款项 | 1,137,226.55 | 354,323.35 | 1,675,616.32 | 868,347.42 |
| 合同负债 | 23,180,180.31 | 33,828,589.41 | 19,568,869.74 | 26,696,597.65 |
| 卖出回购金融资产款 | - | 0 | 0 | 0 |
| 应付手续费及佣金 | - | 0 | - | 0 |
| 应付职工薪酬 | 86,883,335.06 | 70,059,107.58 | 98,200,182.73 | 70,526,095.99 |
| 应交税费 | 60,302,613.69 | 56,379,039.87 | 58,622,439.15 | 57,943,437.92 |
| 其他应付款合计 | 247,177,082.26 | 241,791,293.01 | 233,750,779.04 | 250,094,489.62 |
| 其中:应付利息 | - | 0 | - | 0 |
| 应付股利 | 2,240,000 | 2,240,000 | 2,917,251.4 | 2,240,000 |
| 应付分保账款 | - | 0 | - | 0 |
| 保险合同准备金 | - | 0 | - | 0 |
| 代理买卖证券款 | - | 0 | 0 | 0 |
| 代理承销证券款 | - | 0 | 0 | 0 |
| 一年内到期的非流动负债 | 8,737,094.05 | 8,737,094.05 | 8,737,094.05 | 2,770,319.78 |
| 其他流动负债 | 719,532.12 | 480,844.43 | 423,503.92 | 677,610.04 |
| 流动负债合计 | 967,097,637.52 | 955,286,952.32 | 975,949,164.33 | 960,668,321.51 |
| 非流动负债: | | | | |
| 长期借款 | 150,088,125 | 150,097,916.67 | 150,097,916.67 | 150,088,125 |
| 应付债券 | - | 0 | 0 | 0 |
| 优先股 | - | 0 | 0 | 0 |
| 永续债 | - | 0 | 0 | 0 |
| 租赁负债 | 33,196,922.77 | 33,337,143.71 | 32,980,748.82 | 37,435,132.04 |
| 长期应付款 | - | 0 | 0 | 0 |
| 长期应付职工薪酬 | - | 0 | 0 | 0 |
| 预计负债 | - | 0 | 0 | 0 |
| 递延收益 | 3,462,244.44 | 602,106.46 | 681,968.48 | 761,830.5 |
| 递延所得税负债 | 22,703,877.69 | 25,128,019.14 | 25,009,886.31 | 27,940,823.42 |
| 其他非流动负债 | - | 0 | 0 | 0 |
| 非流动负债合计 | 209,451,169.9 | 209,165,185.98 | 208,770,520.28 | 216,225,910.96 |
| 负债合计 | 1,176,548,807.42 | 1,164,452,138.3 | 1,184,719,684.61 | 1,176,894,232.47 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 621,924,528 | 621,924,528 | 621,924,528 | 621,924,528 |
| 其他权益工具 | - | 0 | 0 | 0 |
| 优先股 | - | 0 | 0 | 0 |
| 永续债 | - | 0 | 0 | 0 |
| 资本公积 | 1,088,273,942.59 | 1,088,273,942.59 | 1,088,273,942.59 | 1,088,273,942.59 |
| 减:库存股 | - | 0 | 0 | 0 |
| 其他综合收益 | 2,512,226.61 | 2,512,226.61 | 2,512,226.61 | 0 |
| 专项储备 | 131,148.08 | 195,341.22 | 142,868.31 | 239,376.25 |
| 盈余公积 | 425,449,851.55 | 425,449,851.55 | 425,449,851.55 | 415,026,062.19 |
| 一般风险准备 | - | 0 | 0 | 0 |
| 未分配利润 | 1,627,609,555.44 | 1,667,422,682.96 | 1,639,419,549.77 | 1,666,899,284.13 |
| 归属于母公司股东权益合计 | 3,765,901,252.27 | 3,805,778,572.93 | 3,777,722,966.83 | 3,792,363,193.16 |
| 少数股东权益 | 1,049,614,719.19 | 1,046,038,075.24 | 1,044,370,308.86 | 1,054,739,521.88 |
| 股东权益合计 | 4,815,515,971.46 | 4,851,816,648.17 | 4,822,093,275.69 | 4,847,102,715.04 |
| 负债和股东权益合计 | 5,992,064,778.88 | 6,016,268,786.47 | 6,006,812,960.3 | 6,023,996,947.51 |
| 公告日期 | 2026-08-29 | 2026-04-28 | 2026-03-31 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |